NON-HODGKIN LYMPHOMA (NHL)
Clinical trials for NON-HODGKIN LYMPHOMA (NHL) explained in plain language.
Never miss a new study
Get alerted when new NON-HODGKIN LYMPHOMA (NHL) trials appear
Sign up with your email to follow new studies for NON-HODGKIN LYMPHOMA (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immune cell shot targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called LV009 injection for people with certain blood cancers (non-Hodgkin lymphoma and acute lymphoblastic leukemia) that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified …
Matched conditions: NON-HODGKIN LYMPHOMA (NHL)
Phase: EARLY_PHASE1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Double-target CAR-T therapy takes on blood cancers that won't quit
Disease control Recruiting nowThis study tests a new type of CAR-T cell therapy that targets two proteins (CD19 and CD20) on cancer cells, aiming to treat adults with B-cell blood cancers like lymphoma and leukemia that have not responded to other treatments. The therapy uses the patient's own immune cells, w…
Matched conditions: NON-HODGKIN LYMPHOMA (NHL)
Phase: PHASE1, PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated May 18, 2026 12:02 UTC